Search Results - "EBBS, Steve R"
-
1
Short-Term Changes in Ki-67 during Neoadjuvant Treatment of Primary Breast Cancer with Anastrozole or Tamoxifen Alone or Combined Correlate with Recurrence-Free Survival
Published in Clinical cancer research (15-01-2005)“…Purpose: Neoadjuvant (preoperative) therapy for breast cancer may allow for the development of intermediate markers of treatment benefit, thereby circumventing…”
Get full text
Journal Article -
2
Biomarker Changes During Neoadjuvant Anastrozole, Tamoxifen, or the Combination: Influence of Hormonal Status and HER-2 in Breast Cancer—A Study from the IMPACT Trialists
Published in Journal of clinical oncology (10-04-2005)“…To investigate the relationships between biomarker changes in breast cancer during neoadjuvant (preoperative) endocrine therapy. The IMPACT trial compared the…”
Get full text
Journal Article -
3
Proliferation and Apoptosis as Markers of Benefit in Neoadjuvant Endocrine Therapy of Breast Cancer
Published in Clinical cancer research (01-02-2006)“…The study of changes in proliferation as a marker of treatment benefit during presurgical endocrine treatment of breast cancer has become increasingly popular,…”
Get full text
Journal Article Conference Proceeding -
4
Ultracision reduces acute blood loss but not seroma formation after mastectomy and axillary dissection: a pilot study
Published in International journal of clinical practice (Esher) (01-05-2006)“…Various surgical cutting coagulation devices are used during breast surgery. A pilot study was set up to determine if ultracision would reduce complications of…”
Get more information
Journal Article -
5
Sentinel node biopsy should be supplemented by axillary sampling in patients with small breast cancers
Published in International seminars in surgical oncology (28-11-2005)“…Axillary clearance provides important prognostic information but is associated with significant morbidity. Sentinel node biopsy can provide staging .141…”
Get full text
Journal Article